{
  "canonical": "https://smarthernews.com/article/astrazeneca_vaccine/",
  "ogUrl": "https://smarthernews.com/article/astrazeneca_vaccine/",
  "ogTitle": "astrazeneca's ceo as the company becomes the third pharmaceutical company in recent weeks to announce promising clinical trial results for a covid-19 vaccine. - smarther news",
  "ogDescription": "today marks an important milestone in our fight against the pandemic.",
  "ogImage": "https://smarthernews.com/wp-content/uploads/2020/04/fusion-medical-animation-EAgGqOiDDMg-unsplash-min-1024x576.jpg",
  "datePublished": "2020-11-23T19:08:11+00:00",
  "dateModified": "2020-11-23T19:13:00+00:00",
  "articleSection": "quick quotes",
  "quote": "Today marks an important milestone in our fight against the pandemic.",
  "summary": "AstraZeneca’s CEO as the company becomes the third pharmaceutical company in recent weeks to announce promising clinical trial results for a COVID-19 vaccine.",
  "featured_image": {
    "imageUrl": "https://smarthernews.com/wp-content/uploads/2020/04/fusion-medical-animation-EAgGqOiDDMg-unsplash-min-1024x576.jpg",
    "alt": ""
  },
  "body": " <ul> <li><strong>THE LATEST:</strong> AstraZeneca’s CEO <a href=\"https://www.astrazeneca.com/content/astraz/media-centre/press-releases/2020/azd1222hlr.html\">says</a> the “<em>vaccine’s efficacy and safety confirm that it will be highly effective against COVID-19 and will have an immediate impact on this public health emergency. Furthermore, the vaccine’s simple supply chain and our no-profit pledge and commitment to broad, equitable and timely access means it will be affordable and globally available, supplying hundreds of millions of doses on approval</em>.” <ul> <li>Last week, Moderna announced the results of its Phase 3 COVID-19 vaccine trial show it’s nearly 95% effective. <ul> <li>Also last week, the U.S. gov’t granted emergency use authorization for a first of its kind at-home COVID-19 test that provides results in 30 min. or less. So far, it’s catching 94% of all positive cases, and 98% of all negative cases.</li> </ul> </li> <li>Two weeks ago, Pfizer announced the results of its Phase 3 COVID-19 vaccine trial show it’s over 90% effective. Pfizer became the first to apply for emergency use authorization from the FDA last week.</li> </ul> </li> <li><strong>ABOUT THE ASTRAZENECA TRIALS: </strong>The trials involve over 23,000 participants in the UK and Brazil. The vaccine was developed by the University of Oxford and AstraZeneca using a weakened version of the common cold virus. <ul> <li>AstraZeneca says its vaccine is at least 62% effective (when given as a half dose followed by a full dose one month later) and up to 90% effective (when given as two full doses one month apart).</li> </ul> </li> <li><strong>FYI:</strong> Unlike the other vaccines, the AstraZeneca vaccine does not need to be stored at ultra-cool temperatures, and it’s expected to be <a href=\"https://apnews.com/article/astrazeneca-vaccine-third-cheaper-oxford-c99d26eb2946f6fde45a1edc002ff028\">less expensive</a> than those from Pfizer and Moderna.</li> <li><strong>BIG PICTURE: </strong>Health and Human Services Secretary Alex Azar said last week that he expects the U.S. will have <a href=\"https://www.c-span.org/video/?c4924104/40-million-covid-19-vaccine-doses-end-year-secretary-azar\">40 million</a> doses of vaccines available for high-risk and vulnerable populations, such as frontline workers, by the end of the year.</li> </ul> ",
  "contentType": "quickquotes"
}